Procalcitonin: Risk Assessment in COVID-19 Bacterial Co-Infection-Sponsored by Thermo Fisher Scientific

Procalcitonin (PCT) is a biomarker widely used to assess the risk of bacterial infection and to aid in antibiotic stewardship in patients with lower respiratory tract infections (LRTI) and sepsis. PCT now also demonstrates evolving evidence as a valuable tool in current COVID-19 epidemics to aid in early identification of patients at low risk of bacterial infection on admission as well as assist in detection of bacterial co-infection in hospitalized patients.